Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Buisson

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
Inflammatory Bowel Diseases|August 9, 2017
Transmural Healing and MRI Remission: New Promising Therapeutic Targets in Crohn's DiseaseAnthony Buisson, Constance Hordonneau, Parakkal Deepak
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2022
ReplyAnthony Buisson, Maria Nachury, Mathurin Fumery
Inflammatory Bowel Diseases|May 2, 2015
What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn's Disease?Anthony Buisson, Constance Hordonneau, Marion Goutte, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2023
Switching From Intravenous to Subcutaneous Infliximab is Safe and Feasible in Patients With Inflammatory Bowel Disease Suffering From Obesity: A Post Hoc Analysis of the REMSWITCH StudyAnthony Buisson, Maria Nachury, Bruno Pereira, et al.
Journal of Gastroenterology|December 31, 2016
What score should be used for evaluation of Crohn's disease severity using magnetic resonance imaging?Anthony Buisson, Constance Hordonneau, Marion Goutte, et al.
Nature Reviews. Gastroenterology & Hepatology|March 6, 2013
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?Laurent Peyrin-Biroulet, Gionata Fiorino, Anthony Buisson, et al.
Inflammatory Bowel Diseases|November 9, 2016
Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's DiseaseAnthony Buisson, Marie-Agnès Bringer, Nicolas Barnich, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2024
How to Incorporate Subcutaneous Infliximab and Vedolizumab in Your PracticeSara N Horst, Melissa Kirkpatrick, Elizabeth Scoville, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 24, 2012
Diagnosis, prevention and treatment of postoperative Crohn's disease recurrenceAnthony Buisson, Jean-Baptiste Chevaux, Gilles Bommelaer, et al.
Therapeutic Advances in Gastroenterology|August 28, 2025
Efficacy of different modalities of faecal microbiota transplantation in ulcerative colitis: systematic review and network meta-analysisJulia Chapon, Julien Scanzi, Harry Sokol, et al.
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Inflammatory Bowel Diseases|August 9, 2017
Transmural Healing and MRI Remission: New Promising Therapeutic Targets in Crohn's DiseaseAnthony Buisson, Constance Hordonneau, Parakkal Deepak
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2022
ReplyAnthony Buisson, Maria Nachury, Mathurin Fumery
Inflammatory Bowel Diseases|May 2, 2015
What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn's Disease?Anthony Buisson, Constance Hordonneau, Marion Goutte, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2023
Switching From Intravenous to Subcutaneous Infliximab is Safe and Feasible in Patients With Inflammatory Bowel Disease Suffering From Obesity: A Post Hoc Analysis of the REMSWITCH StudyAnthony Buisson, Maria Nachury, Bruno Pereira, et al.
Journal of Gastroenterology|December 31, 2016
What score should be used for evaluation of Crohn's disease severity using magnetic resonance imaging?Anthony Buisson, Constance Hordonneau, Marion Goutte, et al.
Nature Reviews. Gastroenterology & Hepatology|March 6, 2013
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?Laurent Peyrin-Biroulet, Gionata Fiorino, Anthony Buisson, et al.
Inflammatory Bowel Diseases|November 9, 2016
Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's DiseaseAnthony Buisson, Marie-Agnès Bringer, Nicolas Barnich, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2024
How to Incorporate Subcutaneous Infliximab and Vedolizumab in Your PracticeSara N Horst, Melissa Kirkpatrick, Elizabeth Scoville, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 24, 2012
Diagnosis, prevention and treatment of postoperative Crohn's disease recurrenceAnthony Buisson, Jean-Baptiste Chevaux, Gilles Bommelaer, et al.
Therapeutic Advances in Gastroenterology|August 28, 2025
Efficacy of different modalities of faecal microbiota transplantation in ulcerative colitis: systematic review and network meta-analysisJulia Chapon, Julien Scanzi, Harry Sokol, et al.
Pageof 17